Literature DB >> 8990401

The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization.

E Bertrand1, D Castanotto, C Zhou, C Carbonnelle, N S Lee, P Good, S Chatterjee, T Grange, R Pictet, D Kohn, D Engelke, J J Rossi.   

Abstract

In order to better understand the influence of RNA transcript context on RNA localization and catalytic RNA efficacy in vivo, we have constructed and characterized several expression cassettes useful for transcribing short RNAs with well defined 5' and 3' appended flanking sequences. These cassettes contain promoter sequences from the human U1 snRNA, U6 snRNA, or tRNA Meti genes, fused to various processing/stabilizing sequences. The levels of expression and the sub-cellular localization of the resulting RNAs were determined and compared with those obtained from Pol II promoters normally linked to mRNA production, which include a cap and polyadenylation signal. The tRNA, Ul, and U6 transcripts were nuclear in localization and expressed at the highest levels, while the standard Pol II promoted transcripts were cytoplasmic and present at lower levels. The ability of these cassettes to confer ribozyme activity in vivo was tested with two assays. First, an SIV-growth hormone reporter gene was transiently transfected into human embryonic kidney cells expressing an anti-SIV ribozyme. Second, cultured T lymphocytes expressing an anti-HIV ribozyme were challenged with HIV. In both cases, we found that the ribozymes were effective only when expressed as capped, polyadenylated RNAs transcribed from Pol II cassettes that generate a cytoplasmically localized ribozyme that facilitates co-localization with its target. We also show that the inability of the other cassettes to support ribozyme-mediated inhibitory activity against their cytoplasmic target is very likely due to the resulting nuclear localization of these ribozymes. These studies demonstrate that the ribozyme expression cassette determines its intracellular localization and, hence, its corresponding functional activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8990401      PMCID: PMC1369464     

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  42 in total

1.  Can hammerhead ribozymes be efficient tools to inactivate gene function?

Authors:  E Bertrand; R Pictet; T Grange
Journal:  Nucleic Acids Res       Date:  1994-02-11       Impact factor: 16.971

2.  Multiple cis-acting signals for export of pre-U1 snRNA from the nucleus.

Authors:  M P Terns; J E Dahlberg; E Lund
Journal:  Genes Dev       Date:  1993-10       Impact factor: 11.361

3.  Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA.

Authors:  B A Sullenger; T R Cech
Journal:  Science       Date:  1993-12-03       Impact factor: 47.728

4.  Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro.

Authors:  P Crisell; S Thompson; W James
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

5.  A kinetic and thermodynamic framework for the hammerhead ribozyme reaction.

Authors:  K J Hertel; D Herschlag; O C Uhlenbeck
Journal:  Biochemistry       Date:  1994-03-22       Impact factor: 3.162

6.  Reduced beta 2-microglobulin mRNA levels in transgenic mice expressing a designed hammerhead ribozyme.

Authors:  S Larsson; G Hotchkiss; M Andäng; T Nyholm; J Inzunza; I Jansson; L Ahrlund-Richter
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

7.  Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena.

Authors:  K Kruger; P J Grabowski; A J Zaug; J Sands; D E Gottschling; T R Cech
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

8.  In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1.

Authors:  K Rittner; C Burmester; G Sczakiel
Journal:  Nucleic Acids Res       Date:  1993-03-25       Impact factor: 16.971

9.  Generating loss-of-function phenotypes of the fushi tarazu gene with a targeted ribozyme in Drosophila.

Authors:  J J Zhao; L Pick
Journal:  Nature       Date:  1993-09-30       Impact factor: 49.962

10.  Beta and gamma actin mRNAs are differentially located within myoblasts.

Authors:  M A Hill; P Gunning
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

View more
  49 in total

1.  Reduction of target gene expression by a modified U1 snRNA.

Authors:  S A Beckley; P Liu; M L Stover; S I Gunderson; A C Lichtler; D W Rowe
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Inhibition of luciferase expression by synthetic hammerhead ribozymes and their cellular uptake.

Authors:  B Bramlage; S Alefelder; P Marschall; F Eckstein
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

3.  Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.

Authors:  P Trang; M Lee; E Nepomuceno; J Kim; H Zhu; F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

4.  HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.

Authors:  B Bramlage; E Luzi; F Eckstein
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

5.  Significantly higher activity of a cytoplasmic hammerhead ribozyme than a corresponding nuclear counterpart: engineered tRNAs with an extended 3' end can be exported efficiently and specifically to the cytoplasm in mammalian cells.

Authors:  T Kuwabara; M Warashina; S Koseki; M Sano; J Ohkawa; K Nakayama; K Taira
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

6.  RNA-protein hybrid ribozymes that efficiently cleave any mRNA independently of the structure of the target RNA.

Authors:  M Warashina; T Kuwabara; Y Kato; M Sano; K Taira
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

7.  Targeting a KH-domain protein with RNA decoys.

Authors:  Aleksandr V Makeyev; Dawn L Eastmond; Stephen A Liebhaber
Journal:  RNA       Date:  2002-09       Impact factor: 4.942

8.  Promoter choice affects the potency of HIV-1 specific RNA interference.

Authors:  Daniel Boden; Oliver Pusch; Fredrick Lee; Lynne Tucker; Peter R Shank; Bharat Ramratnam
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

9.  A functional gene discovery in the Fas-mediated pathway to apoptosis by analysis of transiently expressed randomized hybrid-ribozyme libraries.

Authors:  Hiroaki Kawasaki; Kazunari Taira
Journal:  Nucleic Acids Res       Date:  2002-08-15       Impact factor: 16.971

10.  Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1.

Authors:  Laurent Chaloin; Maik Jörg Lehmann; Georg Sczakiel; Tobias Restle
Journal:  Nucleic Acids Res       Date:  2002-09-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.